報價延遲最少15分鐘:2025/01/21 18:40 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.61 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.99/-0.70
|
|
企業價值
35.33M
|
| 資產負債 |
|
每股賬面淨值
1.30
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
13.80M
|
|
每股收益
2.62
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 18:40 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues. |